Adoxa

Product NDC: 10337-815
11-digit product format: 103370815
Labeler code: 10337
Product ID: 10337-815_26b9e8bd-a1aa-4293-aacc-927cc75149c5
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: doxycycline
Dosage form: CAPSULE
Route: ORAL
Labeler: PharmaDerm a division of Fougera Pharmaceuticals Inc.
Application: ANDA065055
Marketing category: ANDA
Marketing start: 2011-06-01
Marketing end: 0000-00-00
Substance: DOXYCYCLINE
Active strength: 150 mg/1
Pharmacologic classes: Tetracycline-class Drug [EPC],Tetracyclines [CS]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	10337-815		D	Discontinued by firm		2026-09-14
excluded package	package	10337-815	10337-815-06	D	Discontinued by firm		2026-09-14

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	10337-815-06	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	10337-815-06	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	10337-815-06	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	10337-815-06	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	10337-815-06	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	10337-815-06	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	10337-815-06	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	10337-815-06	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	10337-815-06	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	10337-815-06	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	10337-815-06	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	10337-815-06	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	10337-815-06	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	10337-815-06	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	10337-815-06	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	10337-815-06	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	10337-815-06	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	10337-815-06	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	10337-815-06	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	10337-815-06	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	10337-815-06	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065055-001	DOXYCYCLINE	DOXYCYCLINE	EQ 50MG BASE	CAPSULE / ORAL	AB		2000-12-01
A065055-002	DOXYCYCLINE	DOXYCYCLINE	EQ 100MG BASE	CAPSULE / ORAL	AB		2000-12-01
A065055-003	DOXYCYCLINE	DOXYCYCLINE	EQ 150MG BASE	CAPSULE / ORAL	AB	RS	2005-07-15
A065055-004	DOXYCYCLINE	DOXYCYCLINE	EQ 75MG BASE	CAPSULE / ORAL			2005-04-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A065055-001	AB
A065055-002	AB
A065055-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A065055-001	DOXYCYCLINE	EQ 50MG BASE	CAPSULE / ORAL	AB		2000-12-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A065055-002	DOXYCYCLINE	EQ 100MG BASE	CAPSULE / ORAL	AB		2000-12-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A065055-003	DOXYCYCLINE	EQ 150MG BASE	CAPSULE / ORAL	AB	RS	2005-07-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A065055-004	DOXYCYCLINE	EQ 75MG BASE	CAPSULE / ORAL			2005-04-18	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A065055-001	DOXYCYCLINE	EQ 50MG BASE	CAPSULE / ORAL	AB		2000-12-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065055-002	DOXYCYCLINE	EQ 100MG BASE	CAPSULE / ORAL	AB		2000-12-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065055-003	DOXYCYCLINE	EQ 150MG BASE	CAPSULE / ORAL	AB	RS	2005-07-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065055-004	DOXYCYCLINE	EQ 75MG BASE	CAPSULE / ORAL			2005-04-18	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065055-001	DOXYCYCLINE	EQ 50MG BASE	CAPSULE / ORAL	AB		2000-12-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065055-002	DOXYCYCLINE	EQ 100MG BASE	CAPSULE / ORAL	AB		2000-12-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065055-003	DOXYCYCLINE	EQ 150MG BASE	CAPSULE / ORAL	AB	RS	2005-07-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065055-004	DOXYCYCLINE	EQ 75MG BASE	CAPSULE / ORAL			2005-04-18	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065055-001	DOXYCYCLINE	EQ 50MG BASE	CAPSULE / ORAL	AB		2000-12-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065055-002	DOXYCYCLINE	EQ 100MG BASE	CAPSULE / ORAL	AB		2000-12-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065055-003	DOXYCYCLINE	EQ 150MG BASE	CAPSULE / ORAL	AB	RS	2005-07-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065055-004	DOXYCYCLINE	EQ 75MG BASE	CAPSULE / ORAL			2005-04-18	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065055-001	DOXYCYCLINE	EQ 50MG BASE	CAPSULE / ORAL	AB		2000-12-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065055-002	DOXYCYCLINE	EQ 100MG BASE	CAPSULE / ORAL	AB		2000-12-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065055-003	DOXYCYCLINE	EQ 150MG BASE	CAPSULE / ORAL	AB	RS	2005-07-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065055-004	DOXYCYCLINE	EQ 75MG BASE	CAPSULE / ORAL			2005-04-18	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065055-001	DOXYCYCLINE	EQ 50MG BASE	CAPSULE / ORAL	AB		2000-12-01	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065055-002	DOXYCYCLINE	EQ 100MG BASE	CAPSULE / ORAL	AB		2000-12-01	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065055-003	DOXYCYCLINE	EQ 150MG BASE	CAPSULE / ORAL	AB	RS	2005-07-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065055-004	DOXYCYCLINE	EQ 75MG BASE	CAPSULE / ORAL			2005-04-18	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065055-001	DOXYCYCLINE	EQ 50MG BASE	CAPSULE / ORAL	AB		2000-12-01	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065055-002	DOXYCYCLINE	EQ 100MG BASE	CAPSULE / ORAL	AB		2000-12-01	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065055-003	DOXYCYCLINE	EQ 150MG BASE	CAPSULE / ORAL	AB	RS	2005-07-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065055-004	DOXYCYCLINE	EQ 75MG BASE	CAPSULE / ORAL			2005-04-18	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065055-001	DOXYCYCLINE	EQ 50MG BASE	CAPSULE / ORAL	AB		2000-12-01	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065055-002	DOXYCYCLINE	EQ 100MG BASE	CAPSULE / ORAL	AB		2000-12-01	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065055-003	DOXYCYCLINE	EQ 150MG BASE	CAPSULE / ORAL	AB	RS	2005-07-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065055-004	DOXYCYCLINE	EQ 75MG BASE	CAPSULE / ORAL			2005-04-18	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065055-001	DOXYCYCLINE	EQ 50MG BASE	CAPSULE / ORAL	AB		2000-12-01	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065055-002	DOXYCYCLINE	EQ 100MG BASE	CAPSULE / ORAL	AB		2000-12-01	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065055-003	DOXYCYCLINE	EQ 150MG BASE	CAPSULE / ORAL	AB	RS	2005-07-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065055-004	DOXYCYCLINE	EQ 75MG BASE	CAPSULE / ORAL			2005-04-18	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065055-001	DOXYCYCLINE	EQ 50MG BASE	CAPSULE / ORAL	AB		2000-12-01	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065055-002	DOXYCYCLINE	EQ 100MG BASE	CAPSULE / ORAL	AB		2000-12-01	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065055-003	DOXYCYCLINE	EQ 150MG BASE	CAPSULE / ORAL	AB	RS	2005-07-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065055-004	DOXYCYCLINE	EQ 75MG BASE	CAPSULE / ORAL			2005-04-18	`5bbf6a4d5a75…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A065055-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A065055-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A065055-003	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A065055-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065055-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065055-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065055-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065055-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065055-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065055-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065055-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065055-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065055-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065055-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065055-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065055-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065055-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065055-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065055-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065055-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065055-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065055-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065055-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065055-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065055-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065055-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065055-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065055-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065055-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065055-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065055-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065055-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065055-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065055-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065055-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065055-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065055-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065055-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065055-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065055-001	AB	1	`301d65b070ca…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
10337-815-06	2024-08-26	C162847	48780-1	9d75b9d0-3c22-f424-e053-dadaa90a57ce	ADOXA ® DOXYCYCLINE CAPSULES, USP
10337-815-06	2020-01-31	C162847	48780-1	9d75b9d0-3c22-f424-e053-dadaa90a57ce	ADOXA ® DOXYCYCLINE CAPSULES, USP

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
10337-815-06	EA - Each	10337-815	20cd52a3-876f-400b-ab59-9ea3e00c3507	1	2013-06-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DOXYCYCLINE	ACTIVE INGREDIENT	N12000U13O	ADOXA (DOXYCYCLINE) CAPSULE [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.]	1
DOXYCYCLINE ANHYDROUS	ACTIVE MOIETY	334895S862	ADOXA (DOXYCYCLINE) CAPSULE [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ADOXA (DOXYCYCLINE) CAPSULE [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	ADOXA (DOXYCYCLINE) CAPSULE [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	ADOXA (DOXYCYCLINE) CAPSULE [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	ADOXA (DOXYCYCLINE) CAPSULE [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ADOXA (DOXYCYCLINE) CAPSULE [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ADOXA (DOXYCYCLINE) CAPSULE [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	ADOXA (DOXYCYCLINE) CAPSULE [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ADOXA (DOXYCYCLINE) CAPSULE [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Doxycycline	DOXYCYCLINE	Bryant Ranch Prepack	04de98f3-33a2-48ba-85b5-9fac867524b7	2026-07-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065055 application number: ANDA065055
Doxycycline	DOXYCYCLINE	Golden State Medical Supply, Inc.	e9997efa-9ad8-3870-e053-2a95a90a1ac3	2026-07-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065055 application number: ANDA065055
Doxycycline	DOXYCYCLINE	Strides Pharma Science Limited	9e710113-f25e-46fb-8327-7a8e649613a2	2026-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065055 application number: ANDA065055
Doxycycline	DOXYCYCLINE	American Health Packaging	e49f8ff9-af7a-47eb-929b-238cff381c03	2026-04-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065055 application number: ANDA065055
Doxycycline	DOXYCYCLINE	American Health Packaging	3fbf4bb8-036e-41d3-9628-476fc05ddd31	2026-02-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065055 application number: ANDA065055
Doxycycline	DOXYCYCLINE	Bryant Ranch Prepack	6285181d-e34d-4def-abe6-2c41254ada75	2026-02-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065055 application number: ANDA065055
Doxycycline	DOXYCYCLINE	Strides Pharma Science Limited	d27c58a1-5c99-4007-9bc6-ad9b6fb56db8	2025-09-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065055 application number: ANDA065055
Doxycycline	DOXYCYCLINE	NuCare Pharmaceuticals,Inc.	fa1da527-7a0f-8ed6-e053-6394a90a1b62	2024-02-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065055 application number: ANDA065055
Doxycycline	DOXYCYCLINE	Proficient Rx LP	c707566b-dbc7-4dac-bad1-952f2f4d6845	2024-02-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065055 application number: ANDA065055
Doxycycline	DOXYCYCLINE	A-S Medication Solutions	6aab6fee-791e-4141-b55f-685ec9d8712a	2023-11-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065055 application number: ANDA065055

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
N12000U13O	DOXYCYCLINE	17086-28-1	DOXYCYCLINE

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ADOXA ® DOXYCYCLINE CAPSULES, USP	PharmaDerm a division of Fougera Pharmaceuticals Inc. \| Par Pharmaceutical Inc.	2013-05-30	HUMAN PRESCRIPTION DRUG LABEL	1